BLRX stock news · BioLineRx Ltd.
Get alerts for BLRX
Follow BioLineRx Ltd. (BLRX) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for BLRXFree on the App Store and Google Play, or on the web.
BioLineRx will share its third quarter 2026 financial results on November 23, 2026.
NeutralBioLineRx set November 23, 2026, for its third-quarter report and call. The notice gives no financial results, so it does not change the company’s outlook.
BioLineRx and Hemispherian shared new research at ESMO 2026 showing GLIX1 works well with PARP inhibitors.
Good for BLRXBioLineRx reported promising GLIX1 results with PARP inhibitors in ovarian cancer models. The findings support a possible new treatment use, but it still needs study in people.
12 health care stocks are changing in price during Wednesday's after-hours trading.
NeutralBioLine Rx shares fell 7.2% after hours. The story gives no company update, so this move alone does not change its outlook.